Intellia Q3 earnings: Worst performance as March 2027 decision looms
Intellia Q3 earnings reveal a quiet period as all eyes turn to the crucial March 2027 approval decision.
Retail price of drugs: Proven ways to save on medications
Retail price of drugs is crucial for consumers seeking affordable medication options.
BHVN Stock Price: The Best Quick Insights You Need
BHVN stock price insights provide a clear view of market trends and news affecting Biohaven Pharmaceutical.
Citi Pharma Acquisition Approval: Is It the Best Move?
Citi Pharma acquisition approval has been granted, raising questions about its impact on the pharmaceutical industry.
Cancer Drug Price Caps: Are They the Best Solution?
Cancer drug price caps are set to reduce costs by up to 70%.
Are Cancer Drug Prices Falling 70%? The Real Impact
Cancer drug prices are set to fall significantly, with a reduction of up to 70% starting Nov 9.
Cancer Drug Prices: Best Proven Strategy for Affordability
Cancer drug prices may drop significantly as the government caps profit margins at 30%.
Adapalene Gel Pump Packs: Best New Launch in US Market
Adapalene Gel Pump Packs are now available in the US, targeting the OTC market.
Aumolertinib Approval Revoked: What You Need to Know
Aumolertinib approval revoked due to data protection breach. Discover the implications for patients and the pharmaceutical industry.







